2.2 A phase II trial with canakinumab, a new IL-1beta...

Pediatric Rheumatology 2008 / 09 Vol. 6; Iss. 1 Suppleme

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)

N Ruperto, P Quartier, N Wulffraat, P Woo, A Loy, R Mouy, B Bader-Meunier, B Prakken, E Noseda, C Rordorf, Martini for the Paediatric Rheumatology International Trials Organisation (PRINTO) A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Pages:
1
DOI:
10.1186/1546-0096-6-s1-s2
Date:
September, 2008
File:
PDF, 74 KB
english, 2008
Conversion to is in progress
Conversion to is failed